Patents
Sitemap › C07 - Organic chemistry › C07K - Peptides › C07K 14 - Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
Patents for C07K 14 - Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof (291,526)
05/2003
05/22/2003US20030096250 Nucleotide sequences coding polypeptide for use in the prevention of bacterial infection of mammals
05/22/2003US20030096249 Nucleic acid molecules and polypeptides for a human cation channel polypeptide
05/22/2003US20030096247 Human cDNAs and proteins and uses thereof
05/22/2003US20030096243 Measurement of gene expression in target cells; provide genetically engineered cells which express labeled nucleotide sequences, scanning the cells to obtain fluorescent signals, determine concentration of nucleotide sequences
05/22/2003US20030096238 Compositions and methods relating to gynecologic cancer specific genes
05/22/2003US20030096236 Determining common functional alleles in a population and uses therefore
05/22/2003US20030096233 Secreted and transmembrane polypeptides and nucleic acids encoding the same
05/22/2003US20030096221 Methods of identifying g-couple receptors associated with macrophage-thophic hiv, and diagnostic and therapeutic uses thereof
05/22/2003US20030096219 Nucleotide sequence coding polypeptide for use in the treatment of respiratory system disorders
05/22/2003US20030096022 Compositions and methods for the treatment and prevention of cardiovascular diseases and disorders, and for identifying agents therapeutic therefor
05/22/2003US20030095999 The fusogenic protein is associated with a phospholipid membrane, such as a liposome.
05/22/2003US20030095989 Chimeric cytolytic viruses for cancer treatment
05/22/2003US20030095986 Production of a parvovirus vaccine in plants as viral coat protein fusions
05/22/2003US20030095984 Vaccine against mumps containing a Jeryl-Lynn virus strain
05/22/2003US20030095980 Purified hepatitis C virus envelope proteins for diagnostic and therapeutic use
05/22/2003US20030095979 Xn-PeptideL-Xm, where X is Gly, Ala, Val, Leu, Ile, Pro, Phe, Tyr, Trp, Cys, Met, Glu or Asp; and PeptideL is a potentially immunogenic fragment; and a polycationic material; vaccines
05/22/2003US20030095978 Novel adherence factors of non pathogenic microorganisms and applications thereof for screening microorganisms for specific probiotic properties; novel pharmaceutical compositions and food additives comprising such microorganisms and adherence factors
05/22/2003US20030095977 Use of fusion proteins, especially scFvSA, as diagnostic markers or as cell specific targeting agents.
05/22/2003US20030095973 Chlamydia antigens and corresponding DNA fragments and uses thereof
05/22/2003US20030095972 Administration of phosphorylated Mammastatin having a molecular weight of 53 kDa or 49 kDa; the polypeptide is specifically reactive with monoclonal antibody 7G6 that is produced from hybridoma ATCC No. HB10152
05/22/2003US20030095971 Compositions and methods for WT1 specific immunotherapy
05/22/2003US20030095970 PTP05 or PTP10 polypeptide; nucleic acid encoding the peptide and probe for detecting the nucleic acid; recombinant cell; treating diseases caused by PTP abnormality like cancer and diabetes
05/22/2003US20030095969 Administering an anti-VLA-4 antibody, a monoclonal antibody recognizing VLA-4, or a soluble VCAM-1 polypeptide.
05/22/2003US20030095968 Viral encoded semaphorin protein receptor DNA and polypeptides
05/22/2003US20030095967 BAFF, inhibitors thereof and their use in the modulation of B-cell response and treatment of autoimmune disorders
05/22/2003US20030095966 Method of blocking tissue destruction by autoreactive T cells
05/22/2003US20030095964 Process for producing humanized chimera antibody
05/22/2003US20030095962 Chimeric cell-surface receptors that undergo antigen-induced association
05/22/2003US20030095956 Methods of proliferating undifferentiated neural cells
05/22/2003US20030095949 Introducing into cells viral particles or vector that comprise a polynucleotide encoding a serum protein.
05/22/2003US20030095947 Compositions and methods for elimination of unwanted cells
05/22/2003US20030095946 Il-18 as an osteoclastgenic inhibitor
05/22/2003CA2784450A1 Polypeptides of pseudomonas aeruginosa
05/22/2003CA2756866A1 A method of detecting and/or identifying adeno-associated virus (aav) sequences and isolating novel sequences identified thereby
05/22/2003CA2467433A1 Methods of diagnosis of cancer, compositions and methods of screening for modulators of cancer
05/22/2003CA2467347A1 Histamine receptor h3 polynucleotides
05/22/2003CA2467052A1 Immunogenic mimetics of multimer proteins with promiscuous t cell epitope inserts
05/22/2003CA2466878A1 Methods for identifying, isolating, and controlling the growth of estrogen-responsive cells
05/22/2003CA2466843A1 Salmonella vaccine
05/22/2003CA2466769A1 Methods of expressing lim mineralization protein in non-osseous cells
05/22/2003CA2466746A1 Extended native chemical ligation of three or more peptide fragments
05/22/2003CA2466521A1 A nucleic acid encoding a g-protein-coupled receptor, and uses thereof
05/22/2003CA2466420A1 A novel saitohin gene and uses of same
05/22/2003CA2466415A1 Pgc-1.beta., a novel pgc-1 homologue and uses therefor
05/22/2003CA2466346A1 Single nucleotide polymorphisms in gh-1
05/22/2003CA2466279A1 Agents that modulate immune cell activation and methods of use thereof
05/22/2003CA2466043A1 Compounds and methods for treatment and diagnosis of chlamydial infection
05/22/2003CA2465912A1 Eit-6, a polypeptide encoded by an estrogen regulated gene
05/22/2003CA2465868A1 A method of detecting and/or identifying adeno-associated virus (aav) sequences and isolating novel sequences identified thereby
05/22/2003CA2465337A1 Transgenic animal
05/22/2003CA2465214A1 Methods for monitoring polypeptide production and purification using surface enhanced laser desorption/ionization mass spectrometry
05/22/2003CA2464942A1 Signal system and elements used therein
05/22/2003CA2463639A1 Growth hormone variations in humans and their uses
05/22/2003CA2460959A1 Enzymes
05/22/2003CA2454031A1 Novel chromophores/fluorophores and methods for using the same
05/21/2003EP1312680A1 Process for the synthesis of all-D-peptides and peptide nucleic acids
05/21/2003EP1312679A1 Recombinant MVA virus, and the use thereof
05/21/2003EP1312678A1 Recombinant MVA virus, and the use thereof
05/21/2003EP1312677A1 Nucleic acids encoding lettuce big-vein virus proteins and utilization thereof
05/21/2003EP1312675A1 Protein induced by homogeneous blood transfusion and dna encoding the same
05/21/2003EP1312615A2 Exocrine gland tight junction-constituting protein jeap family
05/21/2003EP1312614A1 Polynucleotides and polypeptides of the GCP-2 gene
05/21/2003EP1312613A2 (1--3)-beta-D-glucan binding domain protein, measuring method using the substance and assay kit
05/21/2003EP1312611A1 Method of continuously degrading protein
05/21/2003EP1312377A2 Combined meningitis vaccine
05/21/2003EP1312259A1 Type iii allergic inflammation model animal
05/21/2003EP1311930A2 Systems and methods for authenticating a user to a web server
05/21/2003EP1311704A2 Novel target genes for diseases of the heart
05/21/2003EP1311701A1 Use of b-type natriuretic peptide as a prognostic indicator in acute coronary syndromes
05/21/2003EP1311699A2 Adeno-associated virus-mediated delivery of angiogenic factors
05/21/2003EP1311698A2 Porcine adenovirus type 5 vector and vaccine
05/21/2003EP1311697A2 Constitutive promoter from arabidopsis
05/21/2003EP1311693A2 Transcription factor stress-related proteins and methods of use in plants
05/21/2003EP1311686A2 Modifications of hiv env, gag, and pol enhance immunogenicity for genetic immunization
05/21/2003EP1311685A2 Nucleotide sequences which code for the ccpa1 gene
05/21/2003EP1311684A1 Lactobacillus rhamnosus polynucleotides, polypeptides and methods for using them
05/21/2003EP1311683A1 Nucleotide sequences which code for the csta gene from corynebacterium glutamicum
05/21/2003EP1311682A2 Recombinant constructs of borrelia burgdorferi
05/21/2003EP1311681A2 Nucleic acids compositions conferring dwarfing phenotype
05/21/2003EP1311680A2 Nucleic acid molecules encoding plant cell cycle proteins and uses therefor
05/21/2003EP1311679A2 Interleukin-22 polypeptides, nucleic acids encoding the same and methods for the treatment of pancreatic disorders
05/21/2003EP1311678A2 Cripto tumour polypeptide
05/21/2003EP1311677A2 Regulation of human p2y1-like g protein-coupled receptor
05/21/2003EP1311676A2 Human 7tm proteins and polynucleotides encoding the same
05/21/2003EP1311675A2 Nucleic acid and corresponding protein named 158p1d7 useful in the treatment and detection of bladder and other cancers
05/21/2003EP1311674A2 Compositions and methods for the diagnosis and treatment of tumor
05/21/2003EP1311673A2 Compositions and methods for the therapy and diagnosis of prostate cancer
05/21/2003EP1311671A2 Yeast glucoamylase promoter and uses thereof
05/21/2003EP1311669A1 11 human secreted proteins
05/21/2003EP1311668A2 Compositions and methods for the diagnosis and treatment of tumor
05/21/2003EP1311667A2 Transgenic animal model for neurodegerative disease and uses thereof
05/21/2003EP1311666A2 Progression suppressed gene 13 (psgen 13) and uses thereof
05/21/2003EP1311665A2 Kidney-specific protein
05/21/2003EP1311664A2 Microtubule-associated proteins and tubulins
05/21/2003EP1311663A2 Claudin polypeptides
05/21/2003EP1311549A2 Composition for the elimination of autoreactive b-cells
05/21/2003EP1311547A2 Diagnosis and treatment of cardiovascular conditions
05/21/2003EP1311546A2 Methods for using 14266, a human g protein-coupled receptor
05/21/2003EP1311544A2 Human 7-transmembrane proteins and polynucleotides encoding the same
05/21/2003EP1311543A1 T cell receptor v beta-d beta-j beta sequence and methods for its detection
1 ... 1602 1603 1604 1605 1606 1607 1608 1609 1610 1611 1612 1613 1614 1615 1616 1617 1618 1619 1620 1621 1622 ... 2916